AdvaMed (Advanced Medical Technology Association) represents medical device, diagnostic, and digital health manufacturers in advocacy with FDA, CMS, Congress, and global regulators. Publishes the AdvaMed Code of Ethics governing interactions with healthcare professionals. Its policy work includes FDA user fee negotiations, CMS payment policy, and trade and tax issues, in the US and globally.

Why it matters

AdvaMed Code is the de-facto compliance standard for U.S. MedTech commercial activity, setting expectations for KOL engagement, training, advisory boards, and educational support.

Common pitfalls

•Misinterpreting the AdvaMed Code as a legally binding regulation, rather than an industry-developed ethical guideline.
•Failing to regularly update internal compliance policies to align with revisions to the AdvaMed Code, potentially leading to outdated practices.
•Assuming that adherence to the AdvaMed Code alone guarantees full compliance with all relevant federal and state anti-kickback statutes or fraud and abuse laws.
•Overlooking the global impact of the AdvaMed Code, as many international MedTech companies also consider its principles for their operations.
•Neglecting to adequately train all relevant employees, including sales and marketing teams, on the specific provisions and implications of the AdvaMed Code.

Sources

AdvaMed · AdvaMed
RAPS · RAPS
AAMI · AAMI

Open full page

Select term B to compare.

Why compare MedTech terms side by side?

MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

Common comparison patterns

Regulatory pathway choice - 510(k) vs PMA, 510(k) vs De Novo, Abbreviated vs Special 510(k).
Quality systems - QSR vs ISO 13485, QMSR vs QSR.
Software classification - SaMD vs SiMD, Locked vs adaptive AI.
EU frameworks - MDR vs IVDR, CE Mark vs UKCA.
Cybersecurity artifacts - SPDX vs CycloneDX SBOM, CVE vs CVSS.
Post-market actions - Recall vs field action, Removal vs correction.

How to use this tool

Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.